Decision-making about gene therapy in transfusion dependent thalassemia

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a treatment option with curative intent for patients with transfusion dependent thalassemia (TDT) but its application is limited by the lack of suitable donors and acceptability due to the related morbidity/mortality. Transplantation of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Quarmyne, Maa-Ohui, Ross, Diana, Sinha, Cynthia, Bakshi, Nitya, Boudreaux, Jeanne, Krishnamurti, Lakshmanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461218/
https://www.ncbi.nlm.nih.gov/pubmed/36085025
http://dx.doi.org/10.1186/s12887-022-03598-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461218/
https://www.ncbi.nlm.nih.gov/pubmed/36085025
http://dx.doi.org/10.1186/s12887-022-03598-3

Ejemplares similares